Instrument Inactif

Communiqués Ophthotech Corp Nasdaq

Actions

US6837451037

Recherche biotechnologique et médicale

Communiqués

29/09/23	Loan for Acquisition of U.S. Ophthalmic R&D Company IVERIC bio, Inc. by Astellas Pharma Inc	AQ
12/07/23	Astellas Completes Acquisition of Iveric Bio	PR
05/07/23	Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	BU
15/06/23	IVERIC BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of IVERIC bio, Inc. - ISEE	BU
05/06/23	Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(4)	AQ
02/06/23	Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	BU
24/05/23	Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	BU
11/05/23	IVERIC bio: Q1 Earnings Snapshot	AQ
02/05/23	IVERIC BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of IVERIC bio, Inc. - ISEE	BU
01/05/23	Kyodo News Digest: May 1, 2023 -3-	AQ
01/05/23	IVERIC BIO, INC. : Entry into a Material Definitive Agreement, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits (form 8-K)	AQ
01/05/23	Kyodo News Digest: May 1, 2023 -2-	AQ
01/05/23	Urgent Headline News	AQ
01/05/23	Astellas Enters into Definitive Agreement to Acquire Iveric Bio	PR
01/05/23	Astellas Enters Into Definitive Agreement to Acquire Iveric Bio	BU
23/04/23	Iveric Bio Announces New Functional Vision Loss Reduction Data from Avacincaptad Pegol GATHER Trials Presented at ARVO Annual Meeting	BU
05/04/23	Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(4)	AQ
04/04/23	Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	BU
23/03/23	Iveric Bio : Corporate Overview March 2023	PU
20/03/23	IVERIC BIO, INC. : Entry into a Material Definitive Agreement (form 8-K)	AQ
10/03/23	IVERIC BIO, INC. : Other Events (form 8-K)	AQ
02/03/23	Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	BU
01/03/23	IVERIC BIO, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	AQ
01/03/23	IVERIC bio: Q4 Earnings Snapshot	AQ
01/03/23	Iveric Bio Reports Fourth Quarter and Full Year 2022 Operational Highlights and Financial Results	BU